Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study

Publisher： Karger

E-ISSN： 1423-0399|90|2|161-167

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.90, Iss.2, 2012-11, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study

By  

Urologia Internationalis, Vol. 97, Iss. 3, 2016-04 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms

By Scarpero Harriette   Sand Peter K.   Kelleher Con J.   Berriman Sandra   Bavendam Tamara   Carlsson Martin  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 921-930

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley   Cardozo Linda  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 6, 2015-06 ,pp. : 805-815

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study

By  

LUTS, Vol. 7, Iss. 2, 2015-05 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite